Myriad Genetics Offers Many Types of Molecular Tests Its top seller is the MyRisk Hereditary cancer test, which evaluates 48 genes to help identify a patient's risk of developing 11 different ...

Clinicians reported enhanced confidence in hereditary cancer risk assessment practices, with many expressing intentions to continue using the program. Myriad Genetics emphasizes its commitment to ...

Myriad Genetics, Inc. announced that its MyRisk® Hereditary Cancer Test with RiskScore® was recognized in the American Journal of Human Genetics as one of the top 10 significant advances in ...

Myriad Genetics (MYGN) announced a study revealing that more patients completed hereditary cancer testing when they used an online screening tool and received education about genetic testing.

MYGN sees growth in oncology and women's health testing, but GeneSight coverage loss clouds the near-term outlook.

“Hereditary cancer risk assessment may provide ... For more information, visit www.gabbi.com. About Myriad Genetics Myriad Genetics is a leading molecular diagnostic testing and precision ...

Myriad Genetics has delivered on its diversification promise, thanks to savvy deals, creating real diversification from its core hereditary cancer test franchise. I like the progress being made ...

Myriad Genetics started out as the monopoly in hereditary breast cancer diagnostics. Its oldest test was BRACAnalysis, a predictive test for mutations tied to an increased risk of hereditary ...

Myriad Genetics reported fourth quarter earnings ... ("YoY") and EPS of $0.36 missed by a couple cents. Myriad's core hereditary cancer testing generated 82% of total revenue in the quarter ...

Morningstar brands and products Company Portfolio ...